•  
  •  
  •  
  •  

2025-11-04 04:05:33

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Fabtech Technologies Limited Secures Rs. 52 Crore Contract
  • Power Grid Corporation of India Ltd declares interim dividend of Rs. 4.50
  • Kulin Lalbhai elevated as Chairman of Arvind SmartSpaces Limited
  • Lords Chloro Alkali Ltd enters into lease agreement
  • Tolins Tyres Secures IRT Rate Contract for Supply to Tamil Nadu State Transport Undertakings

Keywords Selected:  VAI

IPO News

  • Manoj Vaibhav Gems 'N' Jewellers Ltd's IPO to open on Friday, September 22, 2023, sets the price band at ₹204 to ₹215 per Equity Share
  • Hyperlocal Jewellery Retail Chain Vaibhav Jewellers gets SEBI nod for its IPO
  • Hyperlocal Jewellery Retail Chain Vaibhav Jewellers files for its IPO

Stock Report

  • Vaibhav Global Ltd declares 2nd interim divdiend of Rs. 1.50
  • Vaibhav Global Ltd consolidated Q2FY26 net profit higher at Rs. 47.55 crores
  • Advait Greenergy Pvt Ltd enters into MoU with Government of Gujarat
  • Advait Energy Transitions Ltd receives order from POWERGRID
  • VGL Conferred with the 'Excellence in Manufacturing Award' by Indo-American Chamber of Commerce
  • Arisinfra and Vaishnavi Residences Launch Arsh Greens, a community of Exclusive Villa Plots "within" the City of Bengaluru
  • Advait Energy Transitions Ltd receives order worth Rs. 80.55 crores
  • Unichem Laboratories Ltd receives EIR from USFDA classifying Roha API facility as VAI
  • SMS Lifesciences India Ltd receives EIR with VAI status from USFDA for API facility at Kazipally
  • EIR from USFDA, for Shilpa Medicare Ltd. Unit VI, Bengaluru.
  • Shalby Ltd and SVVV Indore Forge Strategic Partnership to Launch Healthcare Management Programs
  • Vaibhav Global Limited achieves 'Responsible Jewellery Council (RJC)' Certification
  • Zydus receives EIR for the API manufacturing facility at Dabhasa
  • OneSource's flagship drug-device combination facility in Bangalore maintains its USFDA compliance status
  • USFDA classifies Medgel Pvt Ltd's facility as VAI
  • Crosslay Remedies Ltd acquires land adjacent to Max Super Speciality Hospital, Vaishali
  • Advait Greenergy Pvt Ltd receives various orders worth Rs. 129.39 crores
  • Advait Energy Transitions Ltd accepts orders from Power Grid Corporation of India Ltd
  • Advait Energy Transitions Limited recommends dividend of Rs. 1.75
  • Advait Energy Transitions Ltd Q4 FY2024-25 consolidated profit up at Rs. 11.37 crores
  • USFDA classifies Emcure Pharmaceuticals Ltd's API facility at Kurkumbh as VAI
  • Update on USFDA inspection at manufacturing facility of Medispray in Kundaim, Goa, India
  • Advait Energy Transitions Ltd receives bid confirmation for L1 stage of 11 KW MVCC contract for Amreli Circle
  • Advait Energy Transitions Ltd receives bid confirmation for L1 stage of 11 KW MVCC contract for Bhavnagar Circle

Latest Post

  • Fabtech Technologies Limited Secures Rs. 52 Crore Contract
  • Power Grid Corporation of India Ltd declares interim dividend of Rs. 4.50
  • Kulin Lalbhai elevated as Chairman of Arvind SmartSpaces Limited
  • Lords Chloro Alkali Ltd enters into lease agreement
  • Tolins Tyres Secures IRT Rate Contract for Supply to Tamil Nadu State Transport Undertakings


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024